Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.

about

Alpha Lipoic Acid: A Therapeutic Strategy that Tend to Limit the Action of Free Radicals in Transplantation.

P2860

Q48550553-CC73B775-51ED-4444-8616-C057B5BB4DD6

P2860

Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.

Item

http://www.wikidata.org/entity/Q52843844

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Modulatory effects of alpha-li ...... tivity in obese PCOS patients.

@en

Modulatory effects of alpha-lipoic acid

@nl

type

Item

label

Modulatory effects of alpha-li ...... tivity in obese PCOS patients.

@en

Modulatory effects of alpha-lipoic acid

@nl

prefLabel

Modulatory effects of alpha-li ...... tivity in obese PCOS patients.

@en

Modulatory effects of alpha-lipoic acid

@nl

P1476

Modulatory effects of alpha-li ...... tivity in obese PCOS patients.

@en

P2093

A Manzo

http://www.w3.org/2001/XMLSchema#string

A Napolitano

http://www.w3.org/2001/XMLSchema#string

A Prati

http://www.w3.org/2001/XMLSchema#string

D Della Casa

http://www.w3.org/2001/XMLSchema#string

G Despini

http://www.w3.org/2001/XMLSchema#string

K Shefer

http://www.w3.org/2001/XMLSchema#string

T Simoncini

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria

Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome.

Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.

Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study

Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.

The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization

P2888

s40618-017-0782-z

P304

583-590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40618-017-0782-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro D Genazzani

P577

2017-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29090431

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.

about

P2860

P2860

Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921